Elizabeth R&D Tax Credit Benefits for Businesses

R&D Tax Credits for Elizabeth, New Jersey Businesses

Elizabeth, New Jersey, thrives in industries such as logistics, healthcare, education, retail, and manufacturing. Top companies in the city include the Port Newark-Elizabeth Marine Terminal, a leading logistics hub; Trinitas Regional Medical Center, a major healthcare provider; Kean University, a significant educational institution; Walmart, a key player in the retail sector; and Bayway Refinery, a prominent manufacturing company. The R&D Tax Credit can provide tax savings for these industries by incentivizing innovation and technological advancements.

find out more

Are you eligible?

Why choose us?

Pass an Audit?

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed’s office location at 100 Horizon Center Boulevard, Hamilton, New Jersey is less than 45 miles awayn from Elizabeth and provides R&D tax credit consulting and advisory services to Elizabeth and the surrounsing areas such as: Newark, Jersey City, Paterson, Stamford and Toms River.

If you have any questions or need further assistance, please call or email our local New Jersey Partner on (609) 900-2488.
Feel free to book a quick teleconference with one of our New Jersey R&D tax credit specialists at a time that is convenient for you. Click here for more information about R&D tax credit management and implementation.

Schedule a Teleconference

Elizabeth, New Jersey Patent of the Year – 2024/2025

GenNext Technologies Inc. has been awarded the 2024/2025 Patent of the Year for innovation in protein analysis. Their invention, detailed in U.S. Patent No. 12263477, titled ‘Opto-fluidic array for radical protein foot-printing’, introduces a new platform for mapping protein structures with greater speed and accuracy.

This breakthrough combines light-based control and microfluidics to expose proteins to radicals in a highly controlled environment. The system enables scientists to pinpoint how proteins fold, interact, or change in response to drugs or environmental conditions.

Unlike traditional methods, which can be slow and imprecise, the opto-fluidic array uses focused light to generate hydroxyl radicals that quickly modify proteins at specific locations. These changes reveal structural details critical to understanding disease pathways or developing new therapies.

The compact array can process multiple samples at once, making it well-suited for both academic research and commercial drug development. By simplifying and accelerating structural analysis, the technology lowers costs and shortens discovery timelines.

GenNext Technologies’ invention offers a major advance for structural biology, helping researchers unlock deeper insights into protein function. With this tool, scientists can more easily study proteins in their native environments, leading to better diagnostics, treatments, and biomolecular engineering.